We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

T Cells Engineered To Attack a Variety of Cancers

News   May 04, 2021 | Original story from Massey Cancer Center, Virginia Commonwealth University

 
T Cells Engineered To Attack a Variety of Cancers

Control mice (left panel) with prostate cancer show large areas of metastasis in the lungs (blue). When a subset of animals were treated with unmodified T cells (middle panel), the secondary tumors were smaller than in untreated mice. And when a separate group of mice received T cells engineered to produce MDA-7/IL-24 (right panel), metastases shrunk even more, in some cases down to nothing. Credit: Shawn Wang, PhD

 
 
Advertisement
 

RELATED ARTICLES

Tricking Cancer Cells To Consume Toxic Drugs

News

New research points to a possible strategy to boost tumor intake of cancer drugs, thereby increasing the effectiveness of chemotherapy treatments.

READ MORE

Bioluminescent Tool Makes Animals Glow Like Fireflies

News

An international research team is working to harness the power of bioluminescence in a low-cost, noninvasive portable medical imaging device that could one day be applied to many uses in biomedical research, translational medicine and clinical diagnoses.

READ MORE

Severe COVID-19 Alters Gray Matter Volume in the Brain

News

Covid-19 patients who receive oxygen therapy or experience fever show reduced gray matter volume in the frontal-temporal network of the brain, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE